Abiomed, Inc. (ABMD) - Financial and Strategic SWOT Analysis Review

Date: June 21, 2016
Pages: 49
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A7BCB20E1ADEN
Leaflet:

Download PDF Leaflet

Abiomed, Inc. (ABMD) - Financial and Strategic SWOT Analysis Review
Abiomed, Inc. (ABMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Abiomed, Inc. (Abiomed) is a provider of mechanical circulatory support devices. It undertakes the development, manufacture and marketing of novel technologies designed to replace or assist the pumping function of the failing heart. The company’s heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; as well as percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offer automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It manufactures products in Danvers, Massachusetts; and Aachen, Germany. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed, Inc. Key Recent Developments

May 03, 2016: Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year
Apr 12, 2016: Abiomed Impella Devices Support 37,673 Patients, Enough to Fill Historic Fenway Park
Apr 07, 2016: Abiomed Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery
Feb 08, 2016: Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder to Board of Directors
Feb 04, 2016: Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Abiomed, Inc. - Key Facts
Abiomed, Inc. - Key Employees
Abiomed, Inc. - Key Employee Biographies
Abiomed, Inc. - Major Products and Services
Abiomed, Inc. - Medical Equipment Pipeline Products Data
Abiomed, Inc. Pipeline Products by Equipment Type
Abiomed, Inc. Pipeline Products by Development Stage
Abiomed, Inc. - History
Abiomed, Inc. - Company Statement
Abiomed, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Abiomed, Inc. - Business Description
Abiomed, Inc. - Corporate Strategy
Abiomed, Inc. - SWOT Analysis
SWOT Analysis - Overview
Abiomed, Inc. - Strengths
Strength - Expertise in Circulatory Support
Strength - Research and Development Activities
Strength - Impella Franchise
Abiomed, Inc. - Weaknesses
Weakness - FCA Investigation and Patent Related Concerns
Weakness - Product Safety Concerns
Abiomed, Inc. - Opportunities
Opportunity - The Growing US Healthcare Industry
Opportunity - Increasing Cardiovascular Disease
Opportunity - Regulatory Approvals
Abiomed, Inc. - Threats
Threat - Limited Manufacturing Facilities
Threat - Stiff Competition
Threat - Cost Containment Pressures
Threat - Dependence on Key Suppliers
Abiomed, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Abiomed, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Abiomed, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Abiomed, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 03, 2016: Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year
Apr 12, 2016: Abiomed Impella Devices Support 37,673 Patients, Enough to Fill Historic Fenway Park
Apr 07, 2016: Abiomed Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery
Feb 08, 2016: Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder to Board of Directors
Feb 04, 2016: Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year
Jan 11, 2016: Abiomed Announces Preliminary Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year
Oct 29, 2015: Abiomed Announces Q2 FY 2016 Revenue of $76.4 Million, Up 47% Over Prior Year
Oct 08, 2015: Abiomed's Impella Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions
Oct 08, 2015: Abiomed to Appoint Seth Bilazarian, M.D., New Vice President of Interventional Cardiology Programs
Aug 17, 2015: Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0/LD Pre-Market Approval Supplements

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Abiomed, Inc., Key Facts
Abiomed, Inc., Key Employees
Abiomed, Inc., Key Employee Biographies
Abiomed, Inc., Major Products and Services
Abiomed, Inc. Pipeline Products by Equipment Type
Abiomed, Inc. Number of Pipeline Products by Development Stage
Abiomed, Inc. Pipeline Products Summary by Development Stage
Abiomed, Inc., History
Abiomed, Inc., Subsidiaries
Abiomed, Inc., Key Competitors
Abiomed, Inc., Ratios based on current share price
Abiomed, Inc., Annual Ratios
Abiomed, Inc., Interim Ratios
Abiomed, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Abiomed, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Abiomed, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Abiomed, Inc. Pipeline Products by Equipment Type
Abiomed, Inc. Pipeline Products by Development Stage
Abiomed, Inc., Performance Chart (2012 - 2016)
Abiomed, Inc., Ratio Charts
Abiomed, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Abiomed, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Terumo Heart, Inc.
Teleflex Incorporated
Maquet Cardiovascular, LLC
Jarvik Heart, Inc.
HeartWare International, Inc.
CardiacAssist, Inc.
Skip to top


Ask Your Question

Abiomed, Inc. (ABMD) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: